Reumata OÜ is a OÜ based in Keila linn, registry code 12056499, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €0 with 1 employees.
Turnover
0 €
State taxes
—
Labour taxes
—
Employees
1
±0vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry Scientific research and development · EMTAK 72
Revenue · 202553 191 €
above 87% of companies
industry median 0 € · companies in the industry: 1 073
Net profit margin · 202583.0 %
above 88% of companies
industry median 13.5 % · companies in the industry: 597
Taxes and turnover
Q4 2023 – Q3 2026
Turnover, € Q3 2026: 0 € · industry median 14 442 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Labour taxes per employee, € Q2 2026: 0 € · industry median 1 893 € · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
EmployeesQ3 2026: 1 · +0.0% vs Q2 2026State taxes, € Q2 2026: 41 € · +4 000.0% vs Q1 2026
Figures by quarter
Quarter
Turnover, €
State taxes, €
Labour taxes, €
Employees
Q3 2026
—
—
—
1
Q2 2026
—
41
—
1
Q1 2026
8 011
1
—
1
Q4 2025
24 578
3 144
—
1
Q3 2025
—
282
—
1
Q2 2025
—
33 887
—
1
Q1 2025
22 239
—
—
1
Q4 2024
19 697
1 630
490
1
Q3 2024
6 356
3 492
1 050
—
Q2 2024
77 625
—
—
—
Q1 2024
24 384
—
—
—
Q4 2023
50 223
4 500
—
—
Q3 2023
—
3 241
35
—
Q2 2023
20 706
4 656
1 400
—
Q1 2023
65 361
—
—
—
Q4 2022
93 751
—
—
—
Q3 2022
38 315
751
—
—
Q2 2022
25 247
3 000
—
—
Q1 2022
22 783
9 022
420
—
Turnover per employee in the quarter
0 €
Q3 2026 · calculated from EMTA data
Financials by year
2016 – 2025
Revenue, € thousand 2025: 53 191 € · −63.3% vs 2024 · industry median 0 € · above 87% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit, € thousand 2025: 44 142 € · −68.3% vs 2024 · industry median 0 € · above 92% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Net profit margin, % 2025: 83.0 % · −13.1 pp vs the year before · industry median 13.5 % · above 88% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Assets, € thousand 2025: 35 339 € · −79.4% vs 2024Equity, € thousand 2025: 35 339 € · −79.4% vs 2024Employees2025: 0 · industry median 1 · above 2% of the industry
Company
Industry median
Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.
Financials by year
Year
Revenue, €
Net profit, €
Labour costs, €
Assets, €
Equity, €
Employees
2025
53 191
44 142
0
35 339
35 339
0
2024
145 000
139 305
0
171 805
171 805
0
2023
137 600
109 548
0
156 048
156 048
0
2022
178 875
119 380
0
175 880
175 880
0
2021
82 107
66 857
0
2 500
2 500
0
2020
17 132
4 172
0
2 500
2 500
0
2019
35 836
31 738
0
2 500
2 500
0
2018
—
—
—
—
—
0
2017
—
—
—
—
—
0
2016
—
—
—
—
—
0
2015
—
—
—
—
—
0
2014
—
—
—
—
—
0
2013
—
—
—
—
—
0
2012
—
—
—
—
—
0
2011
—
—
—
—
—
0
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.